Altimmune, Inc. (ALT)
5.52
-0.09
(-1.60%)
USD |
NASDAQ |
Dec 09, 16:00
5.54
+0.02
(+0.36%)
Pre-Market: 08:24
Altimmune Market Cap: 575.97M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 4.214B |
| Eli Lilly & Co. | 879.11B |
| Pfizer Inc. | 144.02B |
| Terns Pharmaceuticals, Inc. | 3.835B |
| Rhythm Pharmaceuticals, Inc. | 6.721B |
Market Cap Related Metrics
| PS Ratio | 21921.58 |
| Price to Book Value | 3.103 |
| Price | 5.52 |
| Earnings Yield | -19.36% |